Stock Yearly Return 2013
Start date: 12/31/2012
End date: 12/31/2013
Start price/share: $5.19
End price/share: $5.55
Dividends collected/share: $0.00
Total return: 6.94%
Average Annual Total Return: 6.94%
Starting investment: $10,000.00
Ending investment: $10,694.00
Years: 1.00


SGYP average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare SGYP average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into SGYP


Also see:
SGYP stock yearly return 2014
SGYP stock yearly return 2015
SGYP stock yearly return 2016
SGYP stock yearly return 2017
SGYP stock yearly return 2018
SGYP stock yearly return 2019
SGYP stock yearly return 2020
SGYP YTD return
SGYP average annual return 10 years
Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. Co. is engaged in the discovery, research and development activities around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Co. discovered, is developing and controls 100% worldwide rights to its proprietary uroguanylin analog platform. Co.'s commercial product, plecanatide, under trademark name TRULANCE™ is for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The SGYP stock yearly return is shown above.

The yearly return on the SGYP stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2013 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the SGYP annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for SGYP:
SGYP SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SGYP (SGYP) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

SIEN Average Annual Return
SIGA Average Annual Return
SLNO Average Annual Return
SLS Average Annual Return
SNDX Average Annual Return
SNGX Average Annual Return
SNNA Average Annual Return
SNOA Average Annual Return
SNSS Average Annual Return
SPNE Average Annual Return
More Healthcare companies »

 

SGYP Stock Yearly Return 2013 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.